dc.contributor.author | YÜCEYAR, AYŞE NUR | |
dc.contributor.author | GÜMÜŞ, HALUK | |
dc.contributor.author | Arslan, Gokhan | |
dc.contributor.author | Kilic, Ahmet Kasim | |
dc.contributor.author | Altintas, Ayse | |
dc.contributor.author | TURAN, ÖMER FARUK | |
dc.contributor.author | Tutuncu, Melih | |
dc.contributor.author | TERZİ, MURAT | |
dc.contributor.author | Acar, Pinar | |
dc.contributor.author | BÜNÜL, SENA DESTAN | |
dc.contributor.author | Balci, Belgin Petek | |
dc.contributor.author | BİR, LEVENT SİNAN | |
dc.contributor.author | Koseoglu, Mesrure | |
dc.contributor.author | Mungan, Semra | |
dc.contributor.author | Gunduz, Tuncay | |
dc.contributor.author | Dogan, Ipek Gungor | |
dc.contributor.author | Kotan, Dilcan | |
dc.contributor.author | Uygunoglu, Ugur | |
dc.contributor.author | EKMEKCİ, ÖZGÜL | |
dc.contributor.author | DEMİRKIRAN, DURUHAN MELTEM | |
dc.contributor.author | KAMIŞLI, ÖZDEN | |
dc.contributor.author | CANBAZ KABAY, SİBEL | |
dc.contributor.author | Tamam, Yusuf | |
dc.contributor.author | Omerhoca, Sami | |
dc.contributor.author | Sevim, Serhan | |
dc.contributor.author | Guler, Sibel | |
dc.contributor.author | Kurtuncu, Murat | |
dc.contributor.author | EFENDİ, HÜSNÜ | |
dc.contributor.author | KARABUDAK, RANA | |
dc.contributor.author | SİVA, AKSEL | |
dc.contributor.author | Sen, Sedat | |
dc.contributor.author | Tuncer, Asli | |
dc.contributor.author | ÖZAKBAŞ, SERKAN | |
dc.contributor.author | Uzunkopru, Cihat | |
dc.contributor.author | Baba, Cavid | |
dc.contributor.author | Demir, Serkan | |
dc.contributor.author | BECKMANN, YEŞİM | |
dc.date.accessioned | 2022-07-04T13:18:23Z | |
dc.date.available | 2022-07-04T13:18:23Z | |
dc.identifier.citation | Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., BECKMANN Y., GÜMÜŞ H., Arslan G., Kilic A. K. , et al., "The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?", MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.58, 2022 | |
dc.identifier.issn | 2211-0348 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_431ca4c6-149b-47e6-a04b-c9d4005a9c68 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/182502 | |
dc.identifier.uri | https://doi.org/10.1016/j.msard.2021.103399 | |
dc.description.abstract | Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Neurology | |
dc.subject | Neurology (clinical) | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course? | |
dc.type | Makale | |
dc.relation.journal | MULTIPLE SCLEROSIS AND RELATED DISORDERS | |
dc.contributor.department | Ondokuz Mayıs Üniversitesi , , | |
dc.identifier.volume | 58 | |
dc.contributor.firstauthorID | 3423529 | |